• Join
  • Login
  • Contact

Search abstracts / presentations

Comparison of efficacy and safety between generic and brand formulations of ceftriaxone

  • In: Hospital Pharmacy - Posters
  • At: Basel (Switzerland) (2008)
  • Type: Poster
  • Poster code: HPS-P-048
  • By: CHEN, Yi-Hsiu (Tzu Chi General Hospital Taipei Branch, Taipei, China Taiwan)
  • Co-author(s): Wu, Ta-Wei (Tzu Chi General Hospital Taipei Branch, TAIPEI, China Taiwan)
  • Abstract:

    After altering the manufacturer of ceftriaxone on Aug 6 2007, physicians responded that the clinical outcomes of brand formulations (denoted Ceftriaxone-B) were more superior than generic formulations (denoted Ceftriaone-G ). In our pilot study, fever reduction attained in 10/34 (29.4%) patients after using Ceftriaxone-B and in 6/36 (16.7%)..

  • The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 28 September 2023

FIP Congresses